Presentations

Share this on: delicious Digg Facebook LinkedIn Twitter Yahoo! Buzz What is this?

Presentations
Talon Therapeutics Corporate Presentation			625.3 KB

Publications
Single-Agent Vincristine Sulfate Liposomes Injection (Marqibo®) Compared to Historical Single-Agent Therapy for Adults with Advanced, Relapsed and/or Refractory Philadelphia Chromosome Negative Acute Lymphoblastic Leukemia	12/11/2011		147.7 KB
VSLI (Vincristine Sulfate Liposomes Injection, Marqibo®) "Bridging" to Potentially Curative Hematopoietic Stem Cell Transplantation (HSCT) in Adults with Philadelphia Chromosome Negative (PH-) Acute Lymphoblastic Leukemia (ALL)	06/09/2011		151.1 KB
VSLI (vincristine sulfate liposomes injection) in the Treatment of Adult Subjects with Advanced, Relapsed/Refractory Acute Lymphoblastic Leukemia (ALL): A Combined Analysis of the VSLI-06 and rALLy Studies	12/05/2010		110.6 KB
Marqibo (vincristine sulfate liposomes injection; VSLI) Optimizes the Dosing, Delivery, and Pharmacokinetic (PK) Profile of Vincristine Sulfate (VCR) in Adults with Relapsed and Refractory Acute Lymphoblastic Leukemia (ALL)	12/05/2010		116.9 KB
A Phase 2 Study of Marqibo® in Adult Patients with Ph- ALL in Second Relapse or Who Progressed Following Two Treatment Lines	12/07/2009		108.6 KB
A Pivotal Study of Marqibo in Adults with Philadelphia Chromosome-Negative Acute Lymphoblastic Leukemia in Second Relapse: Preliminary Results of an Interim Analysis of the rALLy Study	06/02/2009		129.2 KB
A Phase 2 Study of Marqibo in Patients with Metastatic Uveal Melanoma	06/02/2009		83.1 KB
Safety and Efficacy of Marqibo (Vincristine Sulfate Liposomes Injection, OPTISOME™) for the Treatment of Adults with Relapsed or Refractory Acute Lymphocytic Leukemia (ALL)	12/08/2007		88.9 KB
Marqibo (Vincristine Sulfate Liposomes Injection, OPTISOME™) Concentrates Vincristine in Tumor Tissue and Lymphoid Malignancy Oriented Tissues in Tumor-Bearing Mice	12/08/2007		217.4 KB
Vincristine Sulfate Liposomes Injection Concentrates Vincristine in Tumor Tissue and Bone marrow of Tumor-Bearing Mice	10/25/2007		102.9 KB
Vinorelbine Liposomes Injection results in Greater Tumor Drug Exposure Compared to Conventional Vinorelbine in Tumor-Bearing Nude Mice	10/25/2007		92.6 KB
A Pharmacokinetic Study of a Novel Sphingomyelin/Cholesterol Liposomal Topotecan and Non-Liposomal Topotecan in Rats	10/25/2007		103.3 KB
A Phase 1 and Pharmacokinetic (PK) Profile Study of Vinorelbine Liposomes Injection in Patients with Advanced Solid Tumors, Non-Hodgkin's Lymphoma, and Hodgkin's Disease	10/23/2007		62.6 KB
A pharmacokinetic comparison of the Marqibo® 3- and 5-vial injection kits in metastatic melanoma patients	06/03/2007		141.3 KB
Steroids and immunosuppressive agents potentiate the cytotoxicity of the EGFR inhibitor erlotinib (E) in human skin keratinocytes whereas menadione (Vit K3) exerts a protective effect: implications for the management of the skin rash	06/02/2007		618.1 KB
Topical Vitamin K3 (Menadione) Prevents Erlotinib and Cetuximab-Induced EGFR Inhibition in the Skin	06/04/2006		195.3 KB

Investors

Stock Information

Shareholder Tools

Search IR